Sign in

CIK 0001360214 · Large accelerated filer

HARROW, INC.

Sign in to watch
Ticker
HROW
Exchange
Nasdaq
Industry
Pharmaceutical Preparations
FY end
Dec 31
Incorporated
DE
Entity type
operating
EIN
450567010
Phone
615.733.4731
Business address
1A BURTON HILLS BLVD, SUITE 200, NASHVILLE, TN
Former names
HARROW HEALTH, INC., Imprimis Pharmaceuticals, Inc., TRANSDEL PHARMACEUTICALS INC, Bywater Resources, Inc
  1. 4 Derivatives Options or other derivatives
  2. 4 Open-market buy CHIEF EXECUTIVE OFFICER bought 10,000 shares at $30.20 ($302,000)
  3. 4 Open-market buy PRESIDENT AND CFO bought 3,500 shares at $29.90 ($104,650)
  4. 10-Q Report Quarterly Report
  5. SCHEDULE 13G/A Stake Statement of Beneficial Ownership
  6. 8-K Event Results of operations · Regulation FD disclosure
  7. DEFA14A Proxy Proxy Materials
  8. DEF 14A Proxy Proxy Statement
  9. 8-K Event Material agreement · New debt or obligation · Other events
  10. SCHEDULE 13G/A Stake Statement of Beneficial Ownership
  11. 8-K Event Other events
  12. 8-K Event Other events
  13. SCHEDULE 13G Stake Statement of Beneficial Ownership
  14. 8-K Event Regulation FD disclosure
  15. 4 Open-market sale 10% owner sold 198,572 shares at an average $39.51 ($7,846,426)
  16. 4 Open-market sale 10% owner sold 5,000 shares at $54.18 ($270,900)
  17. 10-K Report Annual Report
  18. 8-K Event Results of operations · Regulation FD disclosure
  19. 4 Derivatives Options or other derivatives
  20. 3 Insider Initial Statement of Ownership

Page 2 of 44 · 872 filings